Does Ketamine Work for Anxiety? What the Evidence Shows

Does ketamine work for anxiety? Emerging clinical evidence and a growing body of real-world provider experience suggest it can, particularly for generalized anxiety disorder, social anxiety disorder, and anxiety connected to serious illness or PTSD. Most large trials to date have focused on ketamine's rapid antidepressant effects, but anxiety scores collected alongside those depression studies, plus a smaller set of anxiety-specific trials, point to genuine anxiolytic effects that can occur independent of any change in mood. Ketamine is not FDA-approved for anxiety disorders, so its use here is off-label, meaning providers prescribe it based on clinical judgment and available evidence rather than a specific regulatory indication for anxiety. Here is what the research and clinical experience show so far, and how to think about whether it is worth raising with a provider.

How Ketamine May Help Anxiety

Anxiety disorders involve overactive threat-detection circuits centered on the amygdala, the brain region that processes fear. According to the National Institute of Mental Health (NIMH), the U.S. federal agency responsible for research on mental disorders, an estimated 19.1% of U.S. adults experienced an anxiety disorder in the past year. When these circuits stay stuck in overdrive, the result is persistent worry, physical tension, panic, and avoidance that go well beyond normal concern. Researchers believe ketamine affects anxiety through several overlapping mechanisms.

Glutamate System Modulation

Ketamine's primary action is on NMDA receptors, a type of receptor in the brain's glutamate system that regulates how neurons communicate. By modulating glutamate signaling, ketamine can disrupt entrenched neural patterns that keep anxiety circuits firing on repeat, an effect that may help break the cycle of chronic worry.

Rapid Neuroplasticity

Ketamine promotes neuroplasticity, the growth of new synaptic connections, particularly in the prefrontal cortex, the brain region responsible for regulating emotional responses. Stronger connectivity there may improve the brain's ability to calm the amygdala's fear response.

Default Mode Network Quieting

The default mode network (DMN) is a brain network active during self-referential thinking, including the rumination and worry loops common in anxiety. Ketamine temporarily reduces DMN activity, which may explain the quiet mind effect many anxiety patients describe during and after sessions.

GABA System Effects

Emerging research suggests ketamine may also influence the GABA system, the brain's primary inhibitory neurotransmitter system responsible for calming neural activity. This could offer an additional pathway for anxiety reduction, though this mechanism is less studied than the others.

What the Research Shows

Anxiety disorders frequently co-occur with depression, according to the National Institute of Mental Health, which is one reason many ketamine depression trials also track anxiety outcomes.

Generalized Anxiety Disorder

Studies examining ketamine in patients with co-occurring depression and anxiety have found that infusions reduce anxiety symptoms alongside depressive symptoms. Some of this research suggests ketamine's anxiolytic effects can occur independent of its antidepressant effects, meaning it may help anxiety in its own right rather than only as a byproduct of improved mood.

Social Anxiety Disorder

A study focused specifically on social anxiety disorder found significant symptom reduction after a single IV infusion, with effects appearing within hours and lasting up to two weeks in some patients. The sample size was small, and larger controlled trials are still needed before firm conclusions can be drawn.

Anxiety Related to Serious Illness

Some of the strongest anxiety-related evidence comes from patients facing terminal illness. Ketamine has been studied for existential anxiety in cancer patients and other seriously ill individuals, with reported reductions in anxiety and improvements in quality of life.

PTSD-Related Anxiety

Post-traumatic stress disorder (PTSD) is classified separately from anxiety disorders but shares significant symptom overlap. Research on ketamine for PTSD has shown reductions in both PTSD symptoms and co-occurring anxiety, including hypervigilance and intrusive thoughts.

Obsessive-Compulsive Disorder

Preliminary research has explored ketamine for OCD, a condition driven by anxiety-linked repetitive thoughts and behaviors. Some studies report rapid reductions in obsessive thoughts and compulsive urges, though effects may be short-lived and more research is needed.

What Patients Report

Beyond formal research, clinical experience adds useful context on how ketamine affects anxiety day to day:

• Immediate calm during sessions, with many patients describing the experience as the first time they have felt genuinely calm in years
• Reduced rumination in the days following treatment, with less time spent on "what if" loops and catastrophizing
• Improved sleep, since anxiety frequently disrupts rest and many patients report sleeping better after sessions
• Increased willingness to engage in activities or social situations they had been avoiding
• A more observational, less reactive relationship with anxious thoughts rather than feeling controlled by them

These reports are consistent with provider experience but are not a substitute for controlled research.

What Else to Know Before Starting

If you live with anxiety, the idea of taking a dissociative medication can itself feel anxiety-provoking. Worries about losing control or having a difficult experience are valid and worth raising with your provider directly. Most providers start anxiety patients at lower doses and increase gradually, and many patients find their pre-treatment anxiety resolves once they see how the session actually feels, which for most includes a sense of calm rather than distress. Review our guide on ketamine side effects and safety before your first session.

Ketamine tends to work best for anxiety when paired with other approaches, particularly therapy. Cognitive behavioral therapy, exposure therapy, and mindfulness-based approaches can complement ketamine by helping you build skills for managing anxiety over the long term. Our integration therapy guide covers how to combine the two effectively.

Most providers use the same initial protocol for anxiety as for depression, typically six sessions over two to three weeks for IV infusion, or the standard schedule for Spravato nasal spray (see our comparison of ketamine and esketamine). Some patients notice reduced anxiety within hours of the first session, while others improve gradually over the initial series. Maintenance sessions, commonly every two to four weeks after the initial series, are typically needed to sustain benefits. A provider should track your progress using a standardized tool such as the GAD-7 alongside your self-reported symptoms.